You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Metastatic Pancreas Ductal Adenocarcinoma

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Cancer Trial in Worldwide (PF-05212384, PD-0325901, irinotecan)

Terminated
Has Results
  • Advanced Cancer
  • Los Angeles, California
  • +17 more
Feb 13, 2018

Pancreatic Neuroendocrine Tumour Metastatic Trial in Milan (Everolimus 10 mg daily)

Completed
  • Pancreatic Neuroendocrine Tumour Metastatic
  • Everolimus 10 mg daily
  • Milan, Italy
    European Institute of Oncology
Nov 6, 2018

Ewing Sarcoma, Rhabdomyosarcoma Trial in Singapore (Expanded , Activated NK cells)

Unknown status
  • Ewing Sarcoma
  • Rhabdomyosarcoma
  • Expanded , Activated NK cells
  • Singapore, Singapore
    National University Hospital
Apr 12, 2019

Hyperlipidemia and Mixed Dyslipidemia Trial in Worldwide (Evolocumab, Standard of Care)

Completed
Has Results
  • Hyperlipidemia and Mixed Dyslipidemia
  • Evolocumab
  • Standard of Care
  • Birmingham, Alabama
  • +362 more
May 20, 2019

Solid Tumors Trial in Rozzano (NGR-hTNF)

Completed
  • Solid Tumors
  • Rozzano, Milan, Italy
    Istituto Clinico Humanitas
Aug 27, 2018

Colorectal Cancer Metastatic Trial in Rijeka (Omni-Biotic 10, loperamide ("Seldiar"))

Unknown status
  • Colorectal Cancer Metastatic
  • Omni-Biotic 10
  • loperamide ("Seldiar")
  • Rijeka, Primorsko-goranska, Croatia
    Department of Radiotherapy and Oncology
Oct 10, 2018

NSCLC Trial in Hannover (Enoxaparin, No Enoxaparin)

Terminated
  • Non-small Cell Lung Cancer
  • Hannover, Lower Saxonia, Germany
    Hannover Medical School, Department of Pneumology
Aug 21, 2018

Melanoma Trial in New Haven, Saint Louis (Autologous genetically modified T cells, NY-ESO-1?²5?T)

Terminated
Has Results
  • Melanoma
  • Autologous genetically modified T cells, NY-ESO-1ᶜ²⁵⁹T
  • New Haven, Connecticut
  • +1 more
Jan 8, 2019

Concordance Between ctDNA Assay and FoundationOne

Completed
  • Circulating Tumor DNA
  • +4 more
    • Cambridge, Massachusetts
      Foundation Medicine
    Jul 31, 2018

    Evaluating and Following Breast Cancer Patients in a Better Way

    Unknown status
    • Breast Cancer Female
    • clinical and physical assessment
    • (no location specified)
    Feb 3, 2019

    Tumors Trial in Ancona, Milano (BI 6727, BIBF 1120)

    Completed
    Has Results
    • Neoplasms
    • BI 6727
    • BIBF 1120
    • Ancona, Italy
    • +1 more
    Oct 23, 2017

    Circulating Tumor Cells, Pancreatic Adenocarcinoma, Circulating Tumor DNA (KRAS) Trial in Rouen (Pancreatic adenocarcinoma

    Unknown status
    • Circulating Tumor Cells
    • +3 more
    • Pancreatic adenocarcinoma diagnosis
    • Rouen, France
      UH Rouen
    May 25, 2018

    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Carcinoma, Stage IV Renal Cell Cancer Trial in Australia, Taiwan, United

    Completed
    Has Results
    • Clear Cell Renal Cell Carcinoma
    • +4 more
    • Anti-Endoglin Chimeric Monoclonal Antibody TRC105
    • +3 more
    • Duarte, California
    • +29 more
    Jul 30, 2018

    Locally Advanced or Metastatic Solid Tumors Trial (MK-2206, AZD6244)

    Completed
    Has Results
    • Locally Advanced or Metastatic Solid Tumors
    • (no location specified)
    Nov 3, 2017

    Breast Cancer Trial in Houston (TPI 287, Dexamethasone, Benadryl)

    Completed
    Has Results
    • Breast Cancer
    • TPI 287
    • +3 more
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Sep 18, 2018

    Colon Cancer, Rectal Cancer Trial in Vallejo, Greenville, Scranton (Cetuximab, Irinotecan, IMC-A12 (cixutumumab))

    Terminated
    Has Results
    • Colon Cancer
    • Rectal Cancer
    • Cetuximab
    • +2 more
    • Vallejo, California
    • +2 more
    Jun 1, 2018

    Pancreatic Adenocarcinoma Trial in Spain, Switzerland (NovoTTF-100L, Gemcitabine, nab-Paclitaxel)

    Unknown status
    • Pancreatic Adenocarcinoma
    • NovoTTF-100L
    • +2 more
    • Elche, Spain
    • +5 more
    Sep 12, 2017

    Durvalumab + Tremelimumab Combination Treatment, Pulmonary Sarcomatoid Carcinoma, NSCLC Trial in Seoul (durvalumab +

    Unknown status
    • Durvalumab + Tremelimumab Combination Treatment, Pulmonary Sarcomatoid Carcinoma, NSCLC
    • durvalumab + tremelimumab
    • Seoul, Korea, Republic of
      Department of Internal Medicine, Seoul National University Hospi
    Jun 5, 2018

    NSCLC Trial in United States (PEGylated recombinant human hyaluronidase PH20, Docetaxel)

    Terminated
    Has Results
    • Non-small Cell Lung Cancer
    • PEGylated recombinant human hyaluronidase PH20
    • Docetaxel
    • Encinitas, California
    • +7 more
    Feb 5, 2019

    Elevated Platelet Count as Prognostic Factor in Colorectal

    Completed
    • Colorectal Cancer
    • +2 more
    • Measurement of platelet count at diagnosis
    • Verona, Italy
      Chirurgia Generale ed Epatobiliare, Policlinico GB Rossi
    Oct 23, 2018

    Metastatic Ocular Melanoma, Metastatic Uveal Melanoma Trial run by the NCI (Aldesleukin, Cyclophosphamide, Fludarabine)

    Terminated
    Has Results
    • Metastatic Ocular Melanoma
    • Metastatic Uveal Melanoma
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Sep 10, 2018

    Cardiovascular Disease Trial in Worldwide (bococizumab (PF-04950615), Placebo)

    Terminated
    Has Results
    • Cardiovascular Disease
    • bococizumab (PF-04950615)
    • Placebo
    • Athens, Alabama
    • +1595 more
    Apr 18, 2019

    Pancreatic Cancer, Adenocarcinoma, Pancreatic Tumors Trial in San Francisco, Chicago, Madison (FOLFIRINOX, IPI-926)

    Completed
    • Pancreatic Cancer
    • +2 more
    • FOLFIRINOX, IPI-926
    • San Francisco, California
    • +2 more
    Aug 7, 2017

    Diabetes, Type 2, Cardiovascular Diseases, Risk Factors Trial in Worldwide (Placebo, Canagliflozin (JNJ-28431754) 100 mg,

    Completed
    Has Results
    • Diabetes Mellitus, Type 2
    • +2 more
    • Placebo
    • +2 more
    • Birmingham, Alabama
    • +312 more
    Nov 5, 2018

    Erlotinib Plus Gemcitabine in Metastatic Pancreatic Cancer

    Completed
    Has Results
    • Pancreatic Cancer
    • Köln, Germany
      Klinikum der Universität zu Köln Klinik für Gastroenterologie am
    Oct 12, 2017